Accumulated evidence suggests that aberrant NOTCH1 signaling has been implicated in a variety of tumors9, 10, 11, especially in HNSCC, which surprisingly comprises about 50% of activated mutation in Chinese population12, 13 and 10% in Caucasian population14, 15. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.